{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:54Z","timestamp":1787020734853,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06602-3","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T13:18:15Z","timestamp":1747833495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CircPRDM5-mediated regulation of miR-433-3p and HDAC6 in Parkinson's disease: a novel neuroprotective axis"],"prefix":"10.1186","volume":"23","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"1","key":"6602_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7(1):47.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"6602_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, et al. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):73.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6602_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/S415","volume":"6","author":"JM Beitz","year":"2014","unstructured":"Beitz JM. Parkinson\u2019s disease: a review. Front Biosci (Schol Ed). 2014;6(1):65\u201374.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"5","key":"6602_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, et al. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397.","journal-title":"Lancet Neurol"},{"issue":"9","key":"6602_CR5","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s12031-021-01882-y","volume":"71","author":"J Li","year":"2021","unstructured":"Li J, et al. Role of circRNAs in neurodevelopment and neurodegenerative diseases. J Mol Neurosci. 2021;71(9):1743\u201351.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"6602_CR6","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/jcp.30625","volume":"237","author":"W Huang","year":"2022","unstructured":"Huang W, et al. CircRNA-miRNA networks in regulating bone disease. J Cell Physiol. 2022;237(2):1225\u201344.","journal-title":"J Cell Physiol"},{"issue":"2","key":"6602_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/db20-0203","volume":"70","author":"F Peng","year":"2021","unstructured":"Peng F, et al. circRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 2021;70(2):603\u201315.","journal-title":"Diabetes"},{"issue":"2","key":"6602_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.bbrc.2019.06.087","volume":"516","author":"L Yu","year":"2019","unstructured":"Yu L, Liu Y. circRNA_0016624 could sponge miR-98 to regulate BMP2 expression in postmenopausal osteoporosis. Biochem Biophys Res Commun. 2019;516(2):546\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"6602_CR9","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00018-019-03345-5","volume":"77","author":"R Li","year":"2020","unstructured":"Li R, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77(9):1661\u201380.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"6602_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/kjm2.12799","volume":"40","author":"Z-Z Lan","year":"2024","unstructured":"Lan Z-Z, et al. CircPRDM5 inhibits the proliferation, migration, invasion, and glucose metabolism of gastric cancer cells by reducing GCNT4 expression in a miR-485-3p-dependent manner. Kaohsiung J Med Sci. 2024;40(3):231\u201343.","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"6602_CR11","doi-asserted-by":"publisher","first-page":"e23469","DOI":"10.1002\/jbt.23469","volume":"37","author":"Q Lu","year":"2023","unstructured":"Lu Q, et al. Circ_PRDM5\/miR-25-3p\/ANKRD46 axis is associated with cell malignant behaviors in subjects with breast cancer evaluated by ultrasound. J Biochem Mol Toxicol. 2023;37(11):e23469.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"6602_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10735-021-10053-7","volume":"53","author":"P Huang","year":"2022","unstructured":"Huang P, Hu Y, Duan Y. TGF-\u03b22-induced circ-PRDM5 regulates migration, invasion, and EMT through the miR-92b-3p\/COL1A2 pathway in human lens epithelial cells. J Mol Histol. 2022;53(2):309\u201320.","journal-title":"J Mol Histol"},{"key":"6602_CR13","doi-asserted-by":"publisher","first-page":"148142","DOI":"10.1016\/j.gene.2024.148142","volume":"899","author":"R Liu","year":"2024","unstructured":"Liu R, et al. Serum circPRDM5 as a novel diagnostic biomarker for acute myocardial infarction. Gene. 2024;899:148142.","journal-title":"Gene"},{"key":"6602_CR14","doi-asserted-by":"publisher","first-page":"893713","DOI":"10.3389\/fnins.2022.893713","volume":"16","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, et al. The potential circular RNAs biomarker panel and regulatory networks of Parkinson\u2019s Disease. Front Neurosci. 2022;16:893713.","journal-title":"Front Neurosci"},{"key":"6602_CR15","doi-asserted-by":"publisher","first-page":"114672","DOI":"10.1016\/j.biopha.2023.114672","volume":"162","author":"B Ma","year":"2023","unstructured":"Ma B, et al. Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6602_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ncrna.2023.12.005","volume":"9","author":"J Zhu","year":"2024","unstructured":"Zhu J, et al. Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. Non-coding RNA Res. 2024;9(1):262\u201376.","journal-title":"Non-coding RNA Res"},{"issue":"5","key":"6602_CR17","doi-asserted-by":"publisher","first-page":"e94839","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology. PLoS ONE. 2014;9(5):e94839.","journal-title":"PLoS ONE"},{"key":"6602_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fncel.2017.00170","volume":"11","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s Disease. Front Cell Neurosci. 2017;11:170.","journal-title":"Front Cell Neurosci"},{"key":"6602_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12031-016-0853-1","volume":"61","author":"L Zhang","year":"2017","unstructured":"Zhang L, et al. MicroRNA-433 inhibits the proliferation and migration of HUVECs and neurons by targeting hypoxia-inducible factor 1 alpha. J Mol Neurosci. 2017;61:135\u201343.","journal-title":"J Mol Neurosci"},{"key":"6602_CR20","doi-asserted-by":"publisher","first-page":"111080","DOI":"10.1016\/j.exger.2020.111080","volume":"141","author":"R Wang","year":"2020","unstructured":"Wang R, Zhang J. Clinical significance of miR-433 in the diagnosis of Alzheimer\u2019s disease and its effect on A\u03b2-induced neurotoxicity by regulating JAK2. Exp Gerontol. 2020;141:111080.","journal-title":"Exp Gerontol"},{"issue":"1","key":"6602_CR21","doi-asserted-by":"publisher","first-page":"14666","DOI":"10.1038\/s41598-024-65094-1","volume":"14","author":"N Bahram Sangani","year":"2024","unstructured":"Bahram Sangani N, et al. A novel insight into neurological disorders through HDAC6 protein\u2013protein interactions. Sci Rep. 2024;14(1):14666.","journal-title":"Sci Rep"},{"issue":"7146","key":"6602_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey UB, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447(7146):859\u201363.","journal-title":"Nature"},{"key":"6602_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2020.00078","volume":"12","author":"S Yan","year":"2020","unstructured":"Yan S, et al. Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson\u2019s Disease. Front Aging Neurosci. 2020;12:78.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"6602_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1600-0854.2012.01347.x","volume":"13","author":"C d'Ydewalle","year":"2012","unstructured":"d\u2019Ydewalle C, Bogaert E, Van Den Bosch L. HDAC6 at the intersection of neuroprotection and neurodegeneration. Traffic. 2012;13(6):771\u20139.","journal-title":"Traffic"},{"issue":"5","key":"6602_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology"},{"issue":"12","key":"6602_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"key":"6602_CR27","doi-asserted-by":"publisher","first-page":"106067","DOI":"10.1016\/j.nbd.2023.106067","volume":"180","author":"V Porrini","year":"2023","unstructured":"Porrini V, et al. NF-\u03baB\/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson\u2019s disease patients. Neurobiol Dis. 2023;180:106067.","journal-title":"Neurobiol Dis"},{"key":"6602_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fneur.2019.00826","volume":"10","author":"M Serrao","year":"2019","unstructured":"Serrao M, et al. Prediction of responsiveness of gait variables to rehabilitation training in Parkinson\u2019s Disease. Front Neurol. 2019;10:826.","journal-title":"Front Neurol"},{"issue":"1","key":"6602_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13063-023-07425-7","volume":"24","author":"ZH Jin","year":"2023","unstructured":"Jin ZH, et al. Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson\u2019s disease: study protocol for a randomised, double-blind, controlled trial. Trials. 2023;24(1):410.","journal-title":"Trials"},{"issue":"1","key":"6602_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13063-024-08045-5","volume":"25","author":"HY Zhang","year":"2024","unstructured":"Zhang HY, et al. Transcranial alternating current stimulation improves quality of life in Parkinson\u2019s disease: study protocol for a randomized, double-blind, controlled trial. Trials. 2024;25(1):200.","journal-title":"Trials"},{"issue":"8","key":"6602_CR31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamaneurol.2017.0943","volume":"74","author":"R Pahwa","year":"2017","unstructured":"Pahwa R, et al. ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson Disease (EASE LID Study): a randomized clinical trial. JAMA Neurol. 2017;74(8):941\u20139.","journal-title":"JAMA Neurol"},{"issue":"8","key":"6602_CR32","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","volume":"28","author":"M Zhao","year":"2021","unstructured":"Zhao M, et al. The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson\u2019s disease. Cell Death Differ. 2021;28(8):2517\u201335.","journal-title":"Cell Death Differ"},{"issue":"3","key":"6602_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4314\/ajtcam.v11i3.16","volume":"11","author":"MH Nadri","year":"2014","unstructured":"Nadri MH, et al. Antioxidant activities and tyrosinase inhibition effects of Phaleria macrocarpa extracts. Afr J Tradit Complement Altern Med. 2014;11(3):107\u201311.","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"6602_CR34","doi-asserted-by":"publisher","first-page":"115292","DOI":"10.1016\/j.jep.2022.115292","volume":"294","author":"J Xiao","year":"2022","unstructured":"Xiao J, et al. Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis. J Ethnopharmacol. 2022;294:115292.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"6602_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys. 2011;508(1):1\u201312.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"6602_CR36","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1080\/15548627.2023.2196889","volume":"19","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy. Autophagy. 2023;19(9):2520\u201337.","journal-title":"Autophagy"},{"issue":"5","key":"6602_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-022-04934-2","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, et al. circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p\/\u03b1-syn pathway in Parkinson\u2019s disease. Cell Death Dis. 2022;13(5):477.","journal-title":"Cell Death Dis"},{"issue":"9","key":"6602_CR38","doi-asserted-by":"publisher","first-page":"e11942","DOI":"10.15252\/emmm.201911942","volume":"12","author":"M Hanan","year":"2020","unstructured":"Hanan M, et al. A Parkinson\u2019s disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress. EMBO Mol Med. 2020;12(9):e11942.","journal-title":"EMBO Mol Med"},{"key":"6602_CR39","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.redox.2022.102430","volume":"56","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, et al. CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in Parkinson\u2019s disease. Redox Biol. 2022;56:102430.","journal-title":"Redox Biol"},{"issue":"10","key":"6602_CR40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, et al. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648.","journal-title":"Cell Death Dis"},{"issue":"10","key":"6602_CR41","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/biom13101435","volume":"13","author":"L Nechushtai","year":"2023","unstructured":"Nechushtai L, Frenkel D, Pinkas-Kramarski R. Autophagy in Parkinson\u2019s disease. Biomolecules. 2023;13(10):1435.","journal-title":"Biomolecules"},{"issue":"8","key":"6602_CR42","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, et al. Autophagy in Parkinson\u2019s disease. J Mol Biol. 2020;432(8):2651\u201372.","journal-title":"J Mol Biol"},{"key":"6602_CR43","doi-asserted-by":"publisher","first-page":"100972","DOI":"10.1016\/j.mam.2021.100972","volume":"82","author":"BN Lizama","year":"2021","unstructured":"Lizama BN, Chu CT. Neuronal autophagy and mitophagy in Parkinson\u2019s disease. Mol Aspects Med. 2021;82:100972.","journal-title":"Mol Aspects Med"},{"key":"6602_CR44","first-page":"6564212","volume":"2016","author":"B Cheng","year":"2016","unstructured":"Cheng B, et al. N-acetylcysteine in combination with IGF-1 enhances neuroprotection against proteasome dysfunction-induced neurotoxicity in SH-SY5Y Cells. Parkinsons Dis. 2016;2016:6564212.","journal-title":"Parkinsons Dis"},{"issue":"4","key":"6602_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1750-3639.2003.tb00478.x","volume":"13","author":"JH Zhu","year":"2003","unstructured":"Zhu JH, et al. Localization of phosphorylated ERK\/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol. 2003;13(4):473\u201381.","journal-title":"Brain Pathol"},{"issue":"37","key":"6602_CR46","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay B, et al. Pathogenic lysosomal depletion in Parkinson\u2019s disease. J Neurosci. 2010;30(37):12535\u201344.","journal-title":"J Neurosci"},{"issue":"7","key":"6602_CR47","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/abbs\/gmab055","volume":"53","author":"LI Dong","year":"2021","unstructured":"Dong LI, et al. lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease by impairing miR-374c-5p. Acta Biochim Biophys Sin (Shanghai). 2021;53(7):870\u201382.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"6602_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41420-021-00643-5","volume":"7","author":"L Zuo","year":"2021","unstructured":"Zuo L, et al. 7,8-dihydroxyflavone ameliorates motor deficits via regulating autophagy in MPTP-induced mouse model of Parkinson\u2019s disease. Cell Death Discov. 2021;7(1):254.","journal-title":"Cell Death Discov"},{"issue":"10","key":"6602_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/15548627.2015.1082020","volume":"11","author":"LY Su","year":"2015","unstructured":"Su LY, et al. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA\/\u03b1-synuclein aggregation. Autophagy. 2015;11(10):1745\u201359.","journal-title":"Autophagy"},{"issue":"1\u20132","key":"6602_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2015.05.020","volume":"355","author":"L Haghnejad","year":"2015","unstructured":"Haghnejad L, et al. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson\u2019s disease in Iranian population. J Neurol Sci. 2015;355(1\u20132):72\u20134.","journal-title":"J Neurol Sci"},{"key":"6602_CR51","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fnins.2018.00625","volume":"12","author":"AE Roser","year":"2018","unstructured":"Roser AE, et al. Circulating miRNAs as diagnostic biomarkers for Parkinson\u2019s Disease. Front Neurosci. 2018;12:625.","journal-title":"Front Neurosci"},{"issue":"1","key":"6602_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12935-021-01811-4","volume":"21","author":"W Chen","year":"2021","unstructured":"Chen W, et al. CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p. Cancer Cell Int. 2021;21(1):111.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"6602_CR53","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.3390\/ijms24129975","volume":"24","author":"J Zhao","year":"2023","unstructured":"Zhao J, et al. HDAC6 deficiency has moderate effects on behaviors and Parkinson\u2019s disease pathology in mice. Int J Mol Sci. 2023;24(12):9975.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6602_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1471-4159.2011.07180.x","volume":"117","author":"M Su","year":"2011","unstructured":"Su M, et al. HDAC6 regulates aggresome-autophagy degradation pathway of \u03b1-synuclein in response to MPP+-induced stress. J Neurochem. 2011;117(1):112\u201320.","journal-title":"J Neurochem"},{"issue":"9","key":"6602_CR55","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/jbmr.4339","volume":"36","author":"J Garcia","year":"2021","unstructured":"Garcia J, et al. miR-433-3p suppresses bone formation and mRNAs critical for osteoblast function in mice. J Bone Miner Res. 2021;36(9):1808\u201322.","journal-title":"J Bone Miner Res"},{"issue":"17","key":"6602_CR56","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms23179592","volume":"23","author":"H Jo","year":"2022","unstructured":"Jo H, Shim K, Jeoung D. Targeting HDAC6 to overcome autophagy-promoted anti-cancer drug resistance. Int J Mol Sci. 2022;23(17):9592.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6602_CR57","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/hmg\/ddq083","volume":"19","author":"D Simon","year":"2010","unstructured":"Simon D, et al. A mutation in the 3\u2032-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia. Hum Mol Genet. 2010;19(10):2015\u201327.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6602_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-8-7","volume":"8","author":"C Sim\u00f5es-Pires","year":"2013","unstructured":"Sim\u00f5es-Pires C, et al. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener. 2013;8(1):7.","journal-title":"Mol Neurodegener"},{"key":"6602_CR59","doi-asserted-by":"publisher","first-page":"684714","DOI":"10.3389\/fnmol.2021.684714","volume":"14","author":"K English","year":"2021","unstructured":"English K, Barton MC. HDAC6: a key link between mitochondria and development of peripheral neuropathy. Front Mol Neurosci. 2021;14:684714.","journal-title":"Front Mol Neurosci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06602-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06602-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06602-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:02:50Z","timestamp":1747836170000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06602-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6602"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06602-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experimental procedures involving animals were conducted following ARRIVE guidelines and approved by the Ethics Committee of the General Hospital of Ningxia Medical University (ethics approval number: 2020\u2013624). The study involving human subjects complied with the Declaration of Helsinki and was approved by the ethical committee of our institution (ethics approval number: 2020\u2013624). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}